Jun 26, 2026
17 MIN READ

Understanding and Managing Side Effects of Wegovy

GLP-1 medications like semaglutide cause temporary side effects in most patients, but understanding what to expect and how to manage symptoms helps many people tolerate treatment successfully.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 26, 2026
17 MIN READ

understanding and managing side effects of wegovy — PlexusDx GLP-1 education

Last reviewed: June 26, 2026

Last updated: June 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and other GLP-1 receptor agonists help people lose significant weight by slowing stomach emptying and signaling fullness to the brain—but this mechanism also causes side effects in up to 90% of users during the first few weeks. PlexusDx provides compounded semaglutide injections starting at $149/month, paired with real-time support to help patients navigate adjustment challenges and find their optimal dose.

Common GLP-1 Side Effects and Timeline

The most frequently reported side effects of semaglutide include nausea, vomiting, constipation, and diarrhea, with nausea affecting roughly 25–40% of patients during early treatment weeks. These effects typically peak within the first 2–4 weeks after starting or increasing your dose, then gradually fade as your body adapts to the medication. Appetite suppression, while the desired effect, can feel extreme initially and may require dietary adjustments to ensure adequate nutrition and hydration.

Gastrointestinal symptoms often improve without stopping treatment when patients slow their dose escalation or modify eating patterns. Starting with a lower starting dose and increasing gradually—sometimes called titration—reduces symptom severity compared to jumping to higher doses immediately. PlexusDx works with patients to find the right pace of dose adjustment for their individual tolerance level.

Managing Nausea and Digestive Discomfort

Eating smaller, lower-fat meals spread throughout the day can reduce nausea triggered by GLP-1 medications, since these drugs slow how quickly your stomach processes food. Staying hydrated with water, electrolyte drinks, or broths helps prevent dehydration that may worsen nausea and fatigue. Some patients find that eating protein-rich foods earlier in the day and lighter foods in the evening improves tolerance, while others benefit from ginger tea, peppermint, or B6 supplementation.

If nausea becomes severe enough to interfere with daily life, pausing the dose increase for 1–2 weeks often allows adaptation without stopping treatment entirely. In rare cases where side effects remain intolerable, switching to oral semaglutide or trying a different compound like tirzepatide may help—PlexusDx offers multiple formulations to accommodate different tolerances and preferences.

Constipation, Diarrhea, and Bowel Function Changes

GLP-1 medications slow the movement of food through your digestive tract, which frequently causes constipation in the first 4–8 weeks of treatment. Increasing fiber intake gradually (through vegetables, whole grains, or psyllium supplements), drinking 80–100 ounces of water daily, and adding gentle movement like walking can help restore regular bowel function. Some patients benefit from osmotic laxatives like magnesium citrate or polyethylene glycol, which pull water into the colon without creating dependency.

Paradoxically, some patients experience diarrhea instead, particularly if they eat high-fat or high-sugar foods that their slower digestive system struggles to process. Tracking which foods trigger loose stools helps identify dietary patterns—refined foods, excessive caffeine, and artificial sweeteners often worsen symptoms. As treatment continues, most patients find a new bowel pattern that becomes their baseline within 2–3 months.

Fatigue, Headaches, and Other Systemic Symptoms

Some patients report fatigue or low energy during the first 1–3 weeks of semaglutide, often linked to reduced calorie intake, dehydration, or low blood sugar in people taking diabetes medications. Eating adequate protein (25–35 grams per meal), consuming enough calories to match activity level, and avoiding rapid calorie restriction can minimize fatigue. Headaches occur less frequently but may relate to dehydration or caffeine changes—increasing water intake and maintaining consistent sleep schedules often helps.

If fatigue persists beyond 4 weeks despite adequate nutrition, blood work to check thyroid function, vitamin B12, iron, and glucose levels helps identify correctable causes. PlexusDx patients can coordinate testing through their primary care provider to rule out underlying deficiencies that amplify side effects. Most systemic symptoms resolve completely as the body reaches steady-state on the medication.

When to Adjust Dose or Try a Different Formulation

If side effects remain moderate to severe after 3–4 weeks of consistent eating and hydration adjustments, your PlexusDx care team can pause dose escalation, extend the time between increases, or reduce your current dose temporarily. This approach—sometimes called 'stepping back'—allows your system to adapt without abandoning treatment, and most patients successfully resume dose increases 1–2 weeks later. The goal is finding the dose where weight loss benefits outweigh discomfort.

PlexusDx offers semaglutide injections starting at $149/month, plus oral semaglutide ($249/month), tirzepatide injections ($249/month), and dual-compound GLP-Squared formulations for patients who need alternative options. Oral medications often cause fewer nausea episodes than injections, while tirzepatide (which acts on both GLP-1 and GIP receptors) provides stronger weight loss with a different side effect profile. Patients can also access the Precision Peptide Genetic Test ($99 add-on) to identify genetic factors influencing peptide tolerance and response.

Personalized Dosing and Genetic Insights

Response to GLP-1 medications varies widely based on genetics, with variants in GLP1R, GIPR, MC4R, and FTO genes influencing side effect severity and weight loss outcomes. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides to identify which individuals may experience heightened nausea, appetite suppression, or metabolic responses before starting therapy. This precision approach helps predict tolerability and guide formulation selection from the outset.

Armed with genetic insights, PlexusDx patients can start with a formulation and dosing schedule tailored to their biology rather than following a one-size-fits-all protocol. Some patients with particular genetic profiles tolerate rapid dose escalation well, while others benefit from slower titration or alternative compounds—knowledge that typically takes weeks or months of trial-and-error to discover without testing. This personalized strategy reduces unnecessary suffering and improves long-term treatment success rates.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long do GLP-1 side effects last?

Most side effects peak within 2–4 weeks and gradually improve over 4–8 weeks as your body adapts to the medication. Nausea, the most common symptom, typically resolves within the first month with proper nutrition, hydration, and dose pacing. If side effects persist beyond 8 weeks, PlexusDx can adjust your formulation or dosing strategy to improve tolerance.

Can I prevent nausea before starting semaglutide?

Eating small, protein-rich, low-fat meals starting a few days before your first injection and staying well-hydrated reduces nausea severity. Some patients find that ginger supplements or B6 vitamins (taken preventatively) lower nausea risk, though evidence is modest. SlowDose escalation—starting at the lowest dose and increasing gradually—is the most effective prevention strategy.

What's the cost of PlexusDx compounded semaglutide, and can I adjust my dose without extra charges?

PlexusDx semaglutide injections cost $149/month at the starting tier, with pricing remaining flat regardless of dose adjustments—your dose may need to go up, but your price won't. All medications come from licensed 503A compounding pharmacies, are available in all 50 states, require no insurance, and are HSA/FSA eligible.

Should I stop my GLP-1 medication if side effects are severe?

Stopping abruptly is generally not recommended; instead, pause your dose escalation for 1–2 weeks and allow your body to adapt at the current level. If side effects remain intolerable after 3–4 weeks of dietary and hydration adjustments, PlexusDx can reduce your dose temporarily or switch you to an alternative formulation like oral semaglutide or tirzepatide, which may carry different side effect profiles.

How can genetic testing help me manage side effects?

PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, MC4R, and FTO genes linked to side effect severity and medication response. This $99 add-on (after the first month of treatment) helps predict whether you'll tolerate rapid dose escalation or benefit from slower titration, and guides selection between semaglutide, tirzepatide, or dual-compound options based on your genetic profile.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves